Xeris Biopharma Holdings XERS
NASDAQ XERS
$9.56 -0.42 (-4.21%)
At close: Sep 30, 2026 · 4:00 PM EDT

Xeris Biopharma Holdings (XERS) Operating Expenses (2020 - 2026)

Updated

Xeris Biopharma Holdings (XERS) posted Operating Expenses of $86.93 million for Q2 2026, up 29.6% from $67.06 million a year earlier and up 15.6% from the prior quarter.

Analysis

Xeris Biopharma Holdings (XERS) Operating Expenses (2020 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Operating Expenses at Xeris Biopharma Holdings was $298.82 million, up 16.8% year-over-year; for FY2025, it came in at $266.95 million, up 12.8% from FY2024.

  • Annual Operating Expenses has increased for five consecutive years, with a five-year compound annual growth rate of 20.8% (FY2020 to FY2025).
  • In prior years, Xeris Biopharma Holdings' Operating Expenses was $236.72 million in FY2024 (+13.8%), $207.92 million in FY2023 (+8.2%), $192.19 million in FY2022 (+16.7%) and $164.75 million in FY2021 (+58.4%).
  • The Q2 2026 figure stands as the highest quarterly Operating Expenses in data going back to Q3 2020.
  • On a year-over-year basis, Operating Expenses has increased in each of the last 13 quarters, with growth averaging 17.0% over the last eight quarters.
  • The strongest year-over-year quarter for Operating Expenses in the past five years was Q4 2021, with growth of 114.9%; the weakest was Q4 2022, with a decline of 30.7%.
  • According to Business Quant data, Operating Expenses for the three prior quarters was $75.21 million (Q1 2026), $69.03 million (Q4 2025) and $67.65 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 10.12 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 10.56 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 12.80 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn -6.09 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn -9.70 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 6.54 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 18.20 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 6.68 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 2.09 Bn
10 Xeris Biopharma Holdings 1.73 Bn 1.30 Bn 79.59 Mn 86.93 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 86.93 Mn
Mar 31, 2026 75.21 Mn
Dec 31, 2025 69.03 Mn
Sep 30, 2025 67.65 Mn
Jun 30, 2025 67.06 Mn
Mar 31, 2025 63.21 Mn
Dec 31, 2024 58.42 Mn
Sep 30, 2024 67.16 Mn
Jun 30, 2024 56.25 Mn
Mar 31, 2024 54.88 Mn
Dec 31, 2023 54.23 Mn
Sep 30, 2023 53.23 Mn
Jun 30, 2023 53.99 Mn
Mar 31, 2023 46.47 Mn
Dec 31, 2022 48.31 Mn
Sep 30, 2022 48.51 Mn
Jun 30, 2022 44.22 Mn
Mar 31, 2022 51.15 Mn
Dec 31, 2021 69.70 Mn
Sep 30, 2021 35.42 Mn
API Access

Xeris Biopharma Holdings Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-expenses&ticker=XERS&period=max&api_key=YOUR_API_KEY